We are live on
!
Find out more
PA
PharVision Advisers Portfolio holdings
AUM
$9.86M
1-Year Est. Return
9.93%
This Fund
S&P 500
This Quarter
Est. Return
+0.93%
1 Year Est. Return
+9.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$19.8M
(+11%)
Cap. Flow
+$23.3M
Cap. Flow
% of AUM
11.78%
Top 10 Holdings %
Top 10 Hldgs %
3.45%
Holding
1,063
New
409
Increased
141
Reduced
117
Closed
396
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Delek US
DK
|
+$871K |
| 2 |
Broadcom
AVGO
|
+$691K |
| 3 |
Agilent Technologies
A
|
+$650K |
| 4 |
Telos
TLS
|
+$640K |
| 5 |
Pagaya Technologies
PGY
|
+$627K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Array Technologies
ARRY
|
+$730K |
| 2 |
Vertiv
VRT
|
+$639K |
| 3 |
Zevra Therapeutics
ZVRA
|
+$635K |
| 4 |
BOW
Bowhead Specialty Holdings
BOW
|
+$608K |
| 5 |
Rigel Pharmaceuticals
RIGL
|
+$581K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Industrials | 15.13% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 11.79% |
| 5 | Healthcare | 11.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Matrix Service
MTRX
$347M
| $419K | 0.21% |
35,826
+24,064
| +205% | +$302K |
|
102
Orion
OEC
$379M
| $419K | 0.21% |
+79,369
| New | +$431K |
|
|
HNGE
103
Hinge Health
HNGE
$5.81B
| $417K | 0.21% |
+8,983
| New | +$433K |
|
104
Bright Horizons
BFAM
$4.1B
| $416K | 0.21% |
4,103
-1,139
| -22% | -$115K |
|
105
Alta Equipment Group
ALTG
$208M
| $416K | 0.21% |
90,413
+74,615
| +472% | +$410K |
|
|
PLYM
106
DELISTED
Plymouth Industrial REIT
PLYM
| $414K | 0.21% |
+18,939
| New | +$416K |
|
107
Digital Turbine
APPS
$1.04B
| $414K | 0.21% |
+82,744
| New | +$468K |
|
108
Crown Holdings
CCK
$12.9B
| $414K | 0.21% |
+4,016
| New | +$391K |
|
109
Mission Produce
AVO
$1.12B
| $412K | 0.21% |
35,560
+18,107
| +104% | +$217K |
|
110
Ubiquiti
UI
$32.7B
| $412K | 0.21% |
+745
| New | +$471K |
|
111
LSB Industries
LXU
$824M
| $411K | 0.21% |
48,363
-24,393
| -34% | -$215K |
|
112
Flowserve
FLS
$9.29B
| $411K | 0.21% |
5,924
+448
| +8% | +$28.8K |
|
113
American Water Works
AWK
$26.3B
| $411K | 0.21% |
+3,148
| New | +$421K |
|
114
Zions Bancorporation
ZION
$10B
| $409K | 0.21% |
6,991
+1,209
| +21% | +$65.8K |
|
|
MPT
115
Medical Properties Trust
MPT
$2.86B
| $407K | 0.21% |
81,365
+36,094
| +80% | +$188K |
|
116
Avis
CAR
$5.78B
| $407K | 0.21% |
+3,169
| New | +$442K |
|
117
PubMatic
PUBM
$594M
| $406K | 0.21% |
+45,735
| New | +$398K |
|
118
Valero Energy
VLO
$90.5B
| $405K | 0.21% |
2,487
+790
| +47% | +$134K |
|
119
ABM Industries
ABM
$2.84B
| $404K | 0.2% |
9,557
+4,449
| +87% | +$195K |
|
120
Samsara
IOT
$20.6B
| $404K | 0.2% |
11,399
+2,889
| +34% | +$112K |
|
121
CuriosityStream
CURI
$145M
| $403K | 0.2% |
106,072
+59,132
| +126% | +$263K |
|
122
Centene
CNC
$31.6B
| $402K | 0.2% |
9,774
+3,746
| +62% | +$140K |
|
|
VISN
123
Vistance Networks Inc
VISN
$2.67B
| $402K | 0.2% |
+22,174
| New | +$382K |
|
124
Inspire Medical Systems
INSP
$1.47B
| $402K | 0.2% |
+4,358
| New | +$417K |
|
125
Dillards
DDS
$8.96B
| $401K | 0.2% |
+661
| New | +$416K |
|
Similar funds
BS
RG
MP
CCM
DFA
CCP
FRT
VH
PharVision Advisers's Q4 2025 Portfolio in Review
As of Q4 2025, PharVision Advisers held 1,063 positions worth $198M, up 11% from $178M the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.
PharVision Advisers deployed $23.3M of net new capital in Q4 2025, opening 409 new positions and adding to 141 existing holdings. Its largest new stake was Delek US: 24,407 shares worth $724K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Wayfair, an estimated $510K trimmed.
- PharVision Advisers's largest Q4 2025 buy was Delek US: 24,407 shares worth $724K.
- PharVision Advisers added most to NIO in Q4 2025, an estimated $557K increase.
- PharVision Advisers's biggest Q4 2025 reduction was Wayfair, cutting an estimated $510K.
- PharVision Advisers fully exited Array Technologies in Q4 2025, selling an estimated $730K.
- PharVision Advisers's ten largest holdings make up 3.5% of its $198M portfolio in Q4 2025.
- PharVision Advisers opened 409 new positions and closed 396 in Q4 2025.
- PharVision Advisers's portfolio value rose 11% quarter-over-quarter to $198M.
Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.